Pharmacist involvement in
hospital discharge transitions of
care had a positive impact on
decreasing composite inpatient
readmissions and ED visits,
according to a study published in
the Journal of Hospital Medicine.
The Chicago based paper was the
result of a prospective, randomised,
single-period longitudinal study
using data gathered around 278
patients (141 controls and 137 in
the study group) from Nov 2012
to Jun 2013 at an urban, tertiary,
academic medical center.
The authors concluded that
patients with moderately complex
medication regimens benefited
from a continuity of care involving
a pharmacy team during transitions
in care.The above article was sent to subscribers in Pharmacy Daily's issue from 09 Feb 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Feb 16
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.